tiprankstipranks
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market

Aerovate Therapeutics (AVTE) Income Statement

Compare
125 Followers

Aerovate Therapeutics Income Statement

Last quarter (Q4 2024), Aerovate Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Aerovate Therapeutics's net income was $-5.43M. See Aerovate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -96.00K$ -68.00K$ -15.00K$ -1.00K
Operating Expenses
$ 74.60M$ 81.41M$ 53.24M$ 23.02M$ 8.89M
Depreciation and Amortization
$ 282.00K$ 96.00K$ 68.00K$ 15.00K$ 1.00K
EBITDA
$ -74.31M$ -81.31M$ -53.17M$ -23.01M$ -8.89M
Operating Income
$ -74.60M$ -81.41M$ -53.24M$ -23.02M$ -8.89M
Other Income/Expenses
$ 5.02M$ 5.94M$ 1.75M$ 62.00K$ -722.00K
Pretax Income
$ -69.57M$ -75.47M$ -51.49M$ -22.96M$ -9.61M
Net Income
$ -69.63M$ -75.52M$ -51.51M$ -22.96M$ -9.04M
Per Share Metrics
Basic EPS
$ -2.44$ -2.87$ -2.10$ -0.94$ -0.37
Diluted EPS
$ -2.44$ -2.87$ -2.10$ -0.94$ -0.37
Weighted Average Shares Outstanding
28.58M 26.33M 24.47M 24.41M 24.41M
Weighted Average Shares Outstanding (Diluted)
28.58M 26.33M 24.47M 24.41M 24.41M
Currency in USD

Aerovate Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis